CD177 and myasthenia gravis: Downregulation of other cell surface receptors by autoantibodies, for example NMDA receptors in anti-NMDAR encephalitis and acetylcholine receptors in myasthenia gravis, has been shown to depend upon divalency of the IgG1 molecules (Drachman et al., 1978; Hughes et al., 2010).